Methotrexate in rheumatoid arthritis
- PMID: 20476948
- DOI: 10.1586/1744666X.3.1.27
Methotrexate in rheumatoid arthritis
Abstract
After half a century of use, methotrexate continues to be a cornerstone in the therapy of rheumatoid arthritis. Renewed interest in the 1980s has brought new insights into the mechanisms of action and safety of the drug. The use of combination therapy in rheumatoid arthritis has not masked the value of methotrexate in a competitive market in any way. We review the pharmacodynamics and pharmacokinetics as applicable to its clinical use as an anti-inflammatory and disease-modifying agent here.
Similar articles
-
[Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].Therapie. 1997 Mar-Apr;52(2):133-7. Therapie. 1997. PMID: 9231508 Review. French.
-
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.Semin Arthritis Rheum. 2007 Oct;37(2):99-111. doi: 10.1016/j.semarthrit.2007.02.001. Epub 2007 Mar 27. Semin Arthritis Rheum. 2007. PMID: 17391739 Clinical Trial.
-
Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.Curr Opin Rheumatol. 2007 May;19(3):238-45. doi: 10.1097/BOR.0b013e328099af80. Curr Opin Rheumatol. 2007. PMID: 17414949 Review.
-
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.Arthritis Rheum. 2004 May;50(5):1412-9. doi: 10.1002/art.20221. Arthritis Rheum. 2004. PMID: 15146410 Clinical Trial.
-
Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.Br J Rheumatol. 1998 Oct;37(10):1110-7. Br J Rheumatol. 1998. PMID: 9825751 Clinical Trial.
Cited by
-
Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment.BMC Med. 2011 Jan 13;9:4. doi: 10.1186/1741-7015-9-4. BMC Med. 2011. PMID: 21232092 Free PMC article.
-
Career lifetime advances in rheumatology.Clin Med (Lond). 2010 Apr;10(2):156-9. doi: 10.7861/clinmedicine.10-2-156. Clin Med (Lond). 2010. PMID: 20437989 Free PMC article. No abstract available.
-
A novel dendritic mesoporous silica based sustained hydrogen sulfide donor for the alleviation of adjuvant-induced inflammation in rats.Drug Deliv. 2021 Dec;28(1):1031-1042. doi: 10.1080/10717544.2021.1921075. Drug Deliv. 2021. PMID: 34060389 Free PMC article.
-
Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency.Pharmaceutics. 2022 Nov 30;14(12):2668. doi: 10.3390/pharmaceutics14122668. Pharmaceutics. 2022. PMID: 36559161 Free PMC article.
LinkOut - more resources
Full Text Sources